Search Results - "van Domselaar, M"

Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine‐induced pancreatitis by BERMEJO, F., LOPEZ‐SANROMAN, A., TAXONERA, C., GISBERT, J. P., PÉREZ‐CALLE, J. L., VERA, I., MENCHÉN, L., MARTÍN‐ARRANZ, M. D., OPIO, V., CARNEROS, J. A., VAN‐DOMSELAAR, M., MENDOZA, J. L., LUNA, M., LÓPEZ, P., CALVO, M., ALGABA, A.

“…Summary Background  Pancreatitis is a potentially severe condition. Patients with inflammatory bowel disease (IBD) seem to be at increased risk for acute…”
Get full text

Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease by Bastos Oreiro, M, Castilla-Llorente, C, de la Guía, A L, de Paz, R, Van Domselaar, M, Nieto, J, Rodriguez, A, Gallardo, D, Canales, M

Get full text

Mercaptopurine rescue after azathioprine‐induced liver injury in inflammatory bowel disease by BERMEJO, F., LÓPEZ‐SANROMÁN, A., ALGABA, A., VAN‐DOMSELAAR, M., GISBERT, J. P., GARCÍA‐GARZÓN, S., GARRIDO, E., PIQUERAS, B., DE LA POZA, G., GUERRA, I.

“…Summary Background  Azathioprine (AZA) liver toxicity arises in approximately 3% of inflammatory bowel disease patients and may result in treatment…”
Get full text

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study by Chaparro, M, Verreth, A, Lobaton, T, Gravito-Soares, E, Julsgaard, M, Savarino, E, Magro, F, Biron, Avni I, Lopez-Serrano, P, Casanova, M J, Gompertz, M, Vitor, S, Arroyo, M, Pugliese, D, Zabana, Y, Vicente, R, Aguas, M, Shitrit, Bar-Gil A, Gutierrez, A, Doherty, G A, Fernandez-Salazar, L, Cadilla, Martínez J, Huguet, J M, OʼToole, A, Stasi, E, Marcos, Manceñido N, Villoria, A, Karmiris, K, Rahier, J F, Rodriguez, C, Palomares, Diz-Lois M, Fiorino, G, Benitez, J M, Principi, M, Naftali, T, Taxonera, C, Mantzaris, G, Sebkova, L, Iade, B, Lissner, D, Bradley, Ferrer I, Roman, Lopez-San A, Marin-Jimenez, I, Merino, O, Sierra, M, Van Domselaar, M, Caprioli, F, Guerra, I, Peixe, P, Piqueras, M, Rodriguez-Lago, I, Ber, Y, van Hoeve, K, Torres, P, Gravito-Soares, M, Rudbeck-Resdal, D, Bartolo, O, Peixoto, A, Martin, G, Armuzzi, A, Garre, A, Donday, M G, de Carpi, Martín F J, Gisbert, J P

“…The long-term safety of exposure to anti-tumor necrosis factor (anti-TNFα) drugs during pregnancy has received little attention. We aimed to compare the…”
Get full text

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study by Casanova, M J, Chaparro, M, García-Sánchez, V, Nantes, O, Leo, E, Rojas-Feria, M, Jauregui-Amezaga, A, García-López, S, Huguet, J M, Arguelles-Arias, F, Aicart, M, Marín-Jiménez, I, Gómez-García, M, Muñoz, F, Esteve, M, Bujanda, L, Cortés, X, Tosca, J, Pineda, J R, Mañosa, M, Llaó, J, Guardiola, J, Pérez-Martínez, I, Muñoz, C, González-Lama, Y, Hinojosa, J, Vázquez, J M, Martinez-Montiel, M P, Rodríguez, G E, Pajares, R, García-Sepulcre, M F, Hernández-Martínez, A, Pérez-Calle, J L, Beltrán, B, Busquets, D, Ramos, L, Bermejo, F, Barrio, J, Barreiro-de Acosta, M, Roncedo, O, Calvet, X, Hervías, D, Gomollón, F, Domínguez-Antonaya, M, Alcaín, G, Sicilia, B, Dueñas, C, Gutiérrez, A, Lorente-Poyatos, R, Domínguez, M, Khorrami, S, Muñoz, C, Taxonera, C, Rodríguez-Pérez, A, Ponferrada, A, Van Domselaar, M, Arias-Rivera, M L, Merino, O, Castro, E, Marrero, J M, Martín-Arranz, M, Botella, B, Fernández-Salazar, L, Monfort, D, Opio, V, García-Herola, A, Menacho, M, Ramírez-de la Piscina, P, Ceballos, D, Almela, P, Navarro-Llavat, M, Robles-Alonso, V, Vega-López, A B, Moraleja, I, Novella, M T, Castaño-Milla, C, Sánchez-Torres, A, Benítez, J M, Rodríguez, C, Castro, L, Garrido, E, Domènech, E, García-Planella, E, Gisbert, J P

“…The aims of this study were to assess the risk of relapse after discontinuation of anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory…”
Get full text

Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry by Chaparro, María, Ramas, M, Benítez, J M, López-García, A, Juan, A, Guardiola, J, Mínguez, M, Calvet, X, Márquez, L, Fernández Salazar, L I, Bujanda, L, García, C, Zabana, Y, Lorente, R, Barrio, J, Hinojosa, E, Iborra, M, Cajal, M Domínguez, Van Domselaar, M, García-Sepulcre, M F, Gomollón, F, Piqueras, M, Alcaín, G, García-Sánchez, V, Panés, J, Domènech, E, García-Esquinas, E, Rodríguez-Artalejo, F, Gisbert, J P

“…The objective of this study was (a) To know the prevalence and distribution of extracolonic cancer (EC) in patients with inflammatory bowel disease (IBD); (b)…”
Get full text

Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease by Chaparro, M, Garre, A, Guerra Veloz, M F, Vázquez Morón, J M, De Castro, M L, Leo, E, Rodriguez, E, Carbajo, A Y, Riestra, S, Jiménez, I, Calvet, X, Bujanda, L, Rivero, M, Gomollón, F, Benítez, J M, Bermejo, F, Alcaide, N, Gutiérrez, A, Mañosa, M, Iborra, M, Lorente, R, Rojas-Feria, M, Barreiro-de Acosta, M, Kolle, L, Van Domselaar, M, Amo, V, Argüelles, F, Ramírez, E, Morell, A, Bernardo, D, Gisbert, J P

“…To evaluate the clinical outcomes in patients with IBD after switching from Remicade® to CT-P13 in comparison with patients who maintain Remicade®. Patients…”
Get full text

Southern California Permanent GPS Geodetic Array: Continuous measurements of regional crustal deformation between the 1992 Landers and 1994 Northridge earthquakes by Bock, Y., Wdowinski, S., Fang, P., Zhang, J., Williams, S., Johnson, H., Behr, J., Genrich, J., Dean, J., Domselaar, M., Agnew, D., Wyatt, F., Stark, K., Oral, B., Hudnut, K., King, R., Herring, T., Dinardo, S., Young, W., Jackson, D., Gurtner, W.

“…The southern California Permanent GPS Geodetic Array (PGGA) was established in 1990 across the Pacific‐North America plate boundary to continuously monitor…”
Get full text

Idiopathic acute pancreatitis in patients with inflammatory bowel disease: a multicentric cohort study by García García de Paredes, A., Rodríguez-Escaja, C., Iborra, M., Algaba, A., Cameo, J.I., de la Peña, L., Gomollón, F., Van Domselaar, M., Busta, R., Rodríguez de Santiago, E., Castaño García, A., del Val, A., Bermejo, F., Gutiérrez, A., Guardiola, J., Mesonero, F., Riestra, S., Nos, P., Albillos, A., López-Sanromán, A.

Get full text

Intensification of infliximab therapy in Crohn's disease: efficacy and safety by M Chaparro, Martínez-Montiel, P, Van Domselaar, M, Bermejo, F, Pérez-Calle, J L, Casis, B, Román, A López-San, Algaba, A, Maté, J, Gisbert, J P

“…The response of Crohn's disease (CD) to infliximab is initially good, although a loss of efficacy is observed over time. Dose escalation has been recommended…”
Get full text

Shear-induced diffusion model for microfiltration of polydisperse suspensions by Kromkamp, Janneke, van Domselaar, Mark, Schroën, Karin, van der Sman, Ruud, Boom, Remko

“…A detailed study on concentration polarisation during microfiltration (MF) was carried out in order to improve control on cake layer formation. Concentration…”
Get full text

Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry by Iborra, M., Beltrán, B., Fernández‐Clotet, A., Gutiérrez, A., Antolín, B., Huguet, J.M., De Francisco, R., Merino, O., Carpio, D., García‐López, S., Mesonero, F., Navarro, P., Ferreiro‐Iglesias, R., Carbajo, A.Y., Rivero, M., Gisbert, J.P., Piñero‐Pérez, M.C., Monfort, D., Bujanda, L., García‐Sepulcre, M.F., Martín‐Cardona, A., Cañete, F., Taxonera, C., Domènech, E., Nos, P., Sierra‐Ausín, M., Ferrer‐Rosique, J.A., Martín‐Arranz, M.D., González‐Muñoza, C., Manceñido, N., Rodriguez‐Lago, I., Benítez, J.M., Forés‐Bosch, A., Navarro‐Llavat, M., Calafat, M., Madrigal‐Domínguez, R.E., Arroyo, M., Busquets, D., Lorente, R., Sainz‐Arnau, E., Hernández‐Camba, A., Morales‐Alvarado, V.J., Paredes, J.M., Van Domselaar, M., Hervás, D., Cañada‐Martínez, A., Castro‐Poceiro, J., Cameo‐Lorenzo, J., Fernández‐Salazar, L., Riestra, S., Casas‐Deza, D., Tosca, J., Barrio, J., García, M.J., Chaparro, M.

“…Summary Background There are limited data of ustekinumab administered according to the doses recommended in the UNITI studies. Aim To assess the real‐world,…”
Get full text

Adalimumab in Crohn's disease - data from real life by López San Román, A, Van Domselaar, M, Garrido, E

Get full text

Clinical outcome after anti‐tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long‐term study by Casanova, María José, Chaparro, María, Nantes, Óscar, Benítez, José Manuel, Rojas‐Feria, María, Castro‐Poceiro, Jesús, Huguet, José María, Martín‐Cardona, Albert, Aicart‐Ramos, Marta, Tosca, Joan, Martín‐Rodríguez, María del Mar, González‐Muñoza, Carlos, Mañosa, Miriam, Leo‐Carnerero, Eduardo, Lamuela‐Calvo, Luis Javier, Pérez‐Martínez, Isabel, Bujanda, Luis, Hinojosa, Joaquín, Pajares, Ramón, Argüelles‐Arias, Federico, Pérez‐Calle, José Lázaro, Rodríguez‐González, Gloria Esther, Guardiola, Jordi, Barreiro‐de Acosta, Manuel, Gisbert, Javier P., Bermejo, F., Barrio, J., Beltrán, B., Gomollón, F., Lorente, R., Gutierrez, A., Domínguez‐Cajal, M., Dueñas, C., Ponferrada‐Díaz, A., Van Domselaar, M., Ramírez‐de la Piscina, P., Ramos, L., Almela, P., Navarro‐Llavat, M., Botella, B., Castaño‐Milla, C., Rodríguez, C., Iglesias‐Flores, E., Serrano‐Muñoz, M. J., Ricart, E., Monzó, A., Esteve, M., Garrido, E., Mínguez, M., Cabello‐Tapia, M. J., García‐Planella, E., Domènech, E., Núñez‐Ortiz, A., García‐López, S.

“…Summary Background The long‐term outcome of patients after antitumour necrosis factor alpha (anti‐TNF) discontinuation is not well known. Aims To assess the…”
Get full text

Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project by González-Muñoza, Carlos, Calafat, Margalida, Gisbert, Javier P, Iglesias, Eva, Mínguez, Miguel, Sicilia, Beatriz, Aceituno, Montserrat, Gomollón, Fernando, Calvet, Xavier, Ricart, Elena, De Castro, Luisa, Rivero, Montserrat, Mesonero, Francisco, Márquez, Lucía, Nos, Pilar, Rodríguez-Pescador, Ainhoa, Guardiola, Jordi, García-Sepulcre, MarianaFe, García-López, Santiago, Lorente-Poyatos, Rufo H, Alba, Cristina, Sánchez-Ocaña, Ramon, Vera, Isabel, Madero, Lucía, Riestra, Sabino, Navarro-Llavat, Mercedes, Pérez-Calle, Jose L, Camps, Blau, Van Domselaar, Manuel, Lucendo, Alfredo J, Martín-Arranz, Maria Dolores, Montoro-Huguet, Miguel A, Sierra-Ausín, Mónica, Llaó, Jordina, Carpio, Daniel, Varela, Pilar, Merino, Olga, Fernández-Salazar, Luis I, Piqueras, Marta, Sesé, Eva, Busquets, David, Tardillo, Carlos, Maroto, Nuria, Riera, Joan, Martínez-Flores, Carlos, Muñoz, Fernando, Gordillo-Ábalos, Jordi, Bertoletti, Federico, Garcia-Planella, Esther, Domènech, Eugeni

“…Familial inflammatory bowel disease (IBD) history is a controversial prognostic factor in IBD. We aimed to evaluate the impact of a familial history of IBD on…”
Get full text

P033 Unrevealing new potential key mechanisms implicated in inflammatory bowel disease by multiomic approach by Baldan-Martin, M, Azkargorta, M, Aransay, A M, Gil-Redondo, R, Moreno-Indias, I, Iloro, I, Soleto, I, Orejudo, M, Ramírez, C, Lucendo, A J, Rodríguez Gutiérrez, C, Gutiérrez, A, Martín Arranz, E, Bujanda, L, Rodríguez-Lago, I, Riestra, S, Iglesias-Flores, E, Bermejo, F, Van Domselaar, M, García, M J, Fernández Salazar, L, Barrio Andrés, J, Calvet, X, Torrealba, L, Bastón Rey, I, Pallarés, H, Ber, Y, Carnerero, E L, Casanova, M J, Casals, F, Mendoza, J, Moreno Monteagudo, J A, Millet, Ó, Elortza, F, Mato, J M, Tinahones, F J, Chaparro, M, Gisbert, J P

“…Abstract Background Inflammatory bowel diseases (IBD), comprising Crohn´s disease (CD) and ulcerative colitis (UC), are characterised by chronic, relapsing and…”
Get full text

DOP80 Prevalence and factors associated with Inflammatory Bowel Disease (IBD) activity during pregnancy: updated data from the DUMBO Registry by Chaparro, M, García Donday, M, Núñez Ortiz, A, Calviño Suarez, C, Rubio Iturria, S, Sánchez Azofra, M, Calvo Moya, M, Pérez-Martínez, I, Fernández-Clotet, A, Alfambra, E, Marín Pedrosa, S, Diz-Lois Palomares, M T, Hernandez, V, Ruiz-Cerulla, A, Casanova, M J, Rivero, M, Huguet, J M, Vicente Lidón, R, Árias García, L, Guerra, I, Hervías Cruz, D, Gutiérrez Casbas, A, Bejarano, A, Camargo Camero, R, Rodríguez-Lago, I, Aguas, M, De Jorge Turrión, M Á, Masedo Gonzalez, Á, López Serrano, P, Valldosera Gomis, G, Ceballos, D, Bujanda, L, Molina Arriero, G, Vega Villaamil, P, Van Domselaar, M, Boscá Watts, M M, Lucendo, A J, Zúñiga de Mora-Figueroa, B, Busquets, D, Gisbert, J P

“…Abstract Background IBD remission is key for pregnancy outcomes. Previous studies have suggested a disease recurrence risk of approximately 30% in patients in…”
Get full text

DOP22 Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine by Baldan-Martin, M, Azkargorta, M, Aransay, A M, Gil-Redondo, R, Moreno-Indias, I, Iloro, I, Soleto, I, Orejudo, M, Ramírez, C, Lucendo, A J, Rodríguez Gutiérrez, C, Gutiérrez, A, Martín Arranz, E, Bujanda, L, Rodríguez-Lago, I, Riestra, S, Iglesias-Flores, E, Bermejo, F, Van Domselaar, M, García, M J, Fernández-Salazar, L, García-Alonso, J F, Calvet, X, Torrealba, L, Bastón Rey, I, Pallarés, H, Ber, Y, Carnerero, E L, Casanova, M J, Millet, Ó, Elortza, F, Mato, J M, Tinahones, F J, Chaparro, M, Gisbert, J P

“…Abstract Background Inflammatory bowel diseases are complex conditions characterized by heterogeneity at clinical, immunological, molecular, genetic, and…”
Get full text

DOP08 A novel multiomic approach to unravel the mechanisms of action of biologics and tofacitinib in Inflammatory Bowel Disease by Baldan-Martin, M, Azkargorta, M, Aransay, A M, Gil-Redondo, R, Moreno-Indias, I, Iloro, I, Soleto, I, Orejudo, M, Ramírez, C, Lucendo, A J, Rodríguez Gutiérrez, C, Gutiérrez, A, Martín Arranz, E, Bujanda, L, Rodríguez-Lago, I, Riestra, S, Iglesias-Flores, E, Bermejo, F, Van Domselaar, M, García, M J, Fernández Salazar, L, De Prado, Á, Calvet, X, Torrealba, L, Bastón Rey, I, Pallarés, H, Ber, Y, Carnerero, E L, Casanova, M J, Millet, Ó, Elortza, F, Mato, J M, Tinahones, F J, Chaparro, M, Gisbert, J P

“…Abstract Background Inflammatory bowel diseases (IBD), which includes Crohn´s disease (CD) and ulcerative colitis (UC), are complex and heterogeneous diseases…”
Get full text

P676 Unveiling the impact on in utero exposure to biologic treatments for inflammatory bowel disease (IBD) on children's psychomotor development: Insights from the DUMBO registry of GETECCU by Palomino Pérez, L M, Velasco Rodríguez-Belvís, M, Brenes Ruiz, Y, Leo-Carnerero, E, Calviño Suarez, C, Rivero, M, Calvo, M, Arroyo, M T, Fernández-Clotet, A, Pérez-Martínez, I, Masedo González, Á, Hernández, V, Ruiz-Cerulla, A, López Serrano, P, Vega, P, Rodríguez-Lago, I, Vicente Lidón, R, De Jorge, M Á, Guerra, I, Arias García, L, Molina Arriero, G, Hervías Cruz, D, Busquets, D, Gutiérrez Casbas, A, Van Domselaar, M, Valldosera Gomis, G, Vázquez Morón, J M, Piqueras Cano, M, Lucendo, A J, Martín Arranz, M D, Ramírez de la Piscina, P, Martínez Tirado, M D P, Robles Alonso, V, Marín Pedrosa, S, Camargo Camero, R, Armesto Gonzalez, E, García-Salido, A, Muñoz Codoceo, R, Gisbert, J P, Chaparro, M

“…Abstract Background Understanding the impact of in utero exposure to biologic medications in children is crucial to providing recommendations during pregnancy…”
Get full text